Helms Morten, Ethelberg Steen, Mølbak Kåre
Statens Serum Institut, Copenhagen, Denmark.
Emerg Infect Dis. 2005 Jun;11(6):859-67. doi: 10.3201/eid1106.041017.
The incidence of multidrug-resistant (MDR) Salmonella Typhimurium infections in humans, and in particular MDR definitive phage type 104 (DT104), has increased substantially in many countries in the last 2 decades, often associated with increased illness. To examine the magnitude of this problem, a survey was conducted among countries with available antimicrobial resistance or phage typing surveillance data. A total of 29, primarily industrialized, countries participated in the survey, which covered the years 1992-2001. Overall, the incidence of MDR S. Typhimurium and DT104 increased continuously during this period, although the problem affected primarily Europe and North America. The increase appeared to have peaked in the United Kingdom but not in other countries. Also, the incidence of quinolone-resistant S. Typhimurium was increasing. This survey implies that MDR S. Typhimurium constitutes an increasing public health problem in large parts of the world and emphasizes the importance of surveillance and control programs.
在过去20年里,多重耐药性鼠伤寒沙门氏菌在人类中的感染率,尤其是多重耐药性104型(DT104)的确证噬菌体型,在许多国家大幅上升,且往往伴随着疾病的增加。为了研究这一问题的严重程度,对有可用抗菌药物耐药性或噬菌体分型监测数据的国家进行了一项调查。共有29个主要工业化国家参与了该调查,调查涵盖了1992年至2001年。总体而言,在此期间,多重耐药性鼠伤寒沙门氏菌和DT104的感染率持续上升,尽管该问题主要影响欧洲和北美。这种上升在英国似乎已达到峰值,但在其他国家并非如此。此外,耐喹诺酮鼠伤寒沙门氏菌的感染率也在上升。这项调查表明,多重耐药性鼠伤寒沙门氏菌在世界大部分地区构成了日益严重的公共卫生问题,并强调了监测和控制计划的重要性。